Intech Biopharm Corporation (TPEX: 6461)
Taiwan
· Delayed Price · Currency is TWD
24.30
-0.20 (-0.82%)
Jan 20, 2025, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.33 billion as of January 21, 2025. Its market cap has decreased by -24.12% in one year.
Market Cap
3.33B
Enterprise Value
4.43B
Revenue
34.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.30
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.33B, a decrease of -16.81%. That is a compound annual growth rate of -1.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 230.69B |
Caliway Biopharmaceuticals | 107.71B |
Bora Pharmaceuticals Co., LTD. | 84.53B |
Lotus Pharmaceutical | 68.07B |
Lumosa Therapeutics | 39.86B |
Oneness Biotech | 37.82B |
Polaris Group | 33.06B |
Center Laboratories | 29.18B |